![EU Cover Shot](https://bluematterconsulting.com/wp-content/uploads/2024/10/EU-Cover-Shot.jpg)
This paper by Theo Manolikas (Principal, Blue Matter) and Michelle Lock (Sr. VP and Head of Europe and International, Acceleron Pharma) outlines 6 key models that biotech companies can use to guide the development of their European operations.
This paper by Theo Manolikas (Principal, Blue Matter) and Michelle Lock (Sr. VP and Head of Europe and International, Acceleron Pharma) outlines 6 key models that biotech companies can use to guide the development of their European operations.